Channelopathies in Focus – Marrakech Edition
Marrakech | March 25-29, 2026

 Day Two                           


06:00 - 08:30 am

Breakfast

08:30 - 10:20 am

Session 1. Cardiac Channelopathies

08:30 - 08:35 am

Co-Chairs: Isabelle Baro and Pascale Guicheney

08:35 - 09:05 am

Katja Odening, University of Bern
Novel gene and peptide-based therapies to restore hERG function in the QT syndromes

09:05 - 09:35 am

Carol Ann Remme, Amsterdam UMC
Pharmacological and genetic approaches to target cardiac sodium channels

09:35 - 09:50 am

Nathalie NEYROUD – Sorbonne Université
Enhancing the cardiac sodium current in channelopathies through targeted gene therapy with the Nav1.5 N-terminal domain

09:50 - 10:05 am

Ivy DICK – University of Maryland Baltimore
Diverse Mechanisms in the Pathogenesis of Calcium Channelopathies

10:05 - 10:20 am

Nada BENYAHYA – Mohammed V University of Rabat
Jervell and Lange-Nielsen Syndrome: Molecular Characterization of Two Moroccan Cases with Homozygous KCNQ1 Mutations

10:20 - 10:50 am

Coffee break & poster session

10:50 - 12:40 pm

Session 2. Emerging Topics in Channelopathies 

10:50 - 10:55 am

Chair: Sophie Nicole

10:55 - 11:25 am

Angelika Lampert,  Aachen University Hospital
Decoding Neuropathic Pain: Sodium Channels and Sensory Neuron Subtypes

11:25 - 11:55 am

Mohamed Trebak, University of Pittsburgh
Calcium sensing and ER stress signaling in colorectal cancer

11:55 - 12:10 pm

Anissa Bara –  Sophion Bioscience
Expanding Automated Patch Clamp Across Scales and Systems

12:10 - 12:25 pm

Artem KONDRATSKYI – Nanion Technologies
What to do if you need to functionally characterize 533 ion channel variants

12:25 - 12:40 pm

Dinesh SRINIVASAN – Thryv Therapeutics Inc.
SGK1 Inhibition for Long QT Syndrome and Beyond: A Nodal Strategy for Channelopathies and Cardiac Remodeling

12:40 - 02:40 pm

Lunch & poster session

03:00 - 04:50 pm

Session 3. Organelle Channelopathies 

03:00 - 03:05 pm

Co-chairs: Carol Ann Remme and Hector Valdivia

03:05 - 03:35 pm

David Yule, University of Rochester
Human mutations in Inositol 1,4,5-trisphosphate receptors: multiple mechanisms
leading to pathology

03:35 - 04:05 pm

Dr. Christian Grimm, University of Oxford
Endolysosomal TRPML channels in lung disease

04:05 - 04:35

Coffee break & poster session

04:35 - 04:50 pm

Alia SYEDA – Dalhousie University
TRPML1 Governs Lysosomal pH and mTORC1 Signaling to Support Genome Integrity in Prostate Cancer

04:50 - 05:05 pm

Yvonne E. KLINGL – Ludwig-Maximilians-Universität
TPC1 activity modulation causes iron overload or deficiency by differentially regulating transferrin uptake and endosomal pH

05:05 - 05:20 pm

Débora FALCÓN – University of Seville
Ca²⁺-Sensitive Adenylyl Cyclase 8 as a Key Driver of Orai1 Overexpression Following Myocardial Infarction

07:00 - 09:00 pm

Dinner